Month: <span>August 2018</span>

Home / 2018 / August
Post

Therapy bot for autistic children

ON THE SPECTRUM. A child with autism spectrum disorder (ASD) might have trouble communicating verbally, paying attention to others, or controlling their stress and anxiety. These difficulties can affect the child’s social life and their success in school. Now, a team of researchers from robotics startup LuxAI have created QTrobot, a bot designed to help children with...

Post

Goodbye viral vectors, hello CRISPR

New technique successfully reprograms T cells without using viruses. Researchers from the University of California, San Francisco (CA, USA) have genetically reprogrammed T cells using a CRISPR gene-editing technology. The method could accelerate both research and cell therapy development for a range of diseases. The technique sees quantities of T cells, DNA and the CRISPR...

Post

Amicus secures US approval for Fabry disease drug

Dive Brief: Amicus Therapeutics on Friday won an accelerated U.S. approval of its Fabry disease drug Galafold, giving patients with the rare genetic disorder a new treatment option for the first time in over a decade. The Food and Drug Administration’s OK comes about one year after the agency dropped a requirement for further study of the drug, reversing...

Post

The Rise of Direct Cell Reprogramming

There has been tremendous activity over the last decade in the development of stem cells therapeutics, which have relied on stem cell differentiation protocols, as well as techniques for direct cell reprogramming. Today, there are over 4,700 “stem cell” trials registered on ClinicalTrials.gov and publications have increased dramatically in recent years, demonstrating the rapidly growing interest of the scientific...

Post

High oxidative stress hampers males’ production of powerful blood vessel dilator

MEDICAL COLLEGE OF GEORGIA AT AUGUSTA UNIVERSITY AUGUSTA, Ga. (Aug. 13, 2018) – Higher levels of oxidative stress in males results in lower levels of a cofactor needed to make the powerful blood vessel dilator nitric oxide, researchers report. IMAGE: THIS IS DR. JENNIFER C. SULLIVAN, PHARMACOLOGIST AND PHYSIOLOGIST IN THE DEPARTMENT OF PHYSIOLOGY AT...

Post

Failed antibiotics team up to defeat superbugs

Forget killer robots or zombies – the most plausible doomsday scenario in the next few decades is the so-called superbug, as infectious bacteria become increasingly resistant to our best antibiotics. Now, researchers at Beth Israel Deaconess Medical Center (BIDMC) have found that combining two antibiotics that no longer work can create a treatment that’s once...

Post

Mechanism of fibrosis development discovered

Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease of unknown origin with limited treatment options. Research suggests that the signaling molecule WNT5A plays a key role in the pathogenic process. Now, a group of scientists from Helmholtz Center Munich, working with colleagues from the University of Denver, have taken a further step toward uncovering...

Post

Cannabis link to relieving intestinal inflammation explained

Reports from cannabis users that the drug reduces the symptoms of inflammatory bowel disease (IBD) may finally be explained by new research from the University of Massachusetts Medical School and the University of Bath showing that endocannabinoids help control and prevent intestinal inflammation in mice. Credit: CC0 Public Domain  This is the first-time scientists have...